Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.

Pharmaceutical

Pharma Mar SA

D. José María Fernández Sousa-Faro

Ali Zeaiter

Carmen Cuevas Marchante

María Lisa Basile

Juan Gómez Pulido

Luis Mora Capitán

José María Jimeno

Luis Rupérez Cuenca

José Luis Moreno Martínez-Losa

María José Arce-Tomas

Pascal Besman

Sandra Llamera Sánchez

Lara Vadillo

Heiner Pieper

Carmen Eibe

Elisa Borrego

José Luis Ortega Conejero

María Luisa de Francia Caballero

The Research and Development Team at Pharma Mar SA is focused on advancing the company’s portfolio of bio-therapeutic drugs derived from marine sources. This team conducts innovative research to discover and develop new compounds, oversee clinical trials, and ensure compliance with regulatory standards. They collaborate closely to explore potential treatments for cancer and viral diseases, as well as optimize formulations and delivery methods, ultimately contributing to the development of groundbreaking therapies for human health.

Research and Development Team

Global Commercial Team

Leadership Team

Finance and Compliance Team

Research and Development Team

About

Team members

Other teams at Pharma Mar SA

Global Commercial Team

Leadership Team

Finance and Compliance Team